Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesReevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity
Journal of Rheumatology, 10/20/09
Khan NA et al. – MS duration has a moderate correlation with RA disease activity. Assessment of MS duration may be clinically helpful in patients with low RAPID3 scores.
Methods- 5439 patients in QUEST-RA
- MS duration assessed from time of waking to time of maximal improvement
- Ability of MS duration to differentiate RA activity states, based on Disease Activity Score (DAS)28, assessed by analysis of variance; and receiver-operating characteristic (ROC) curve plotted for discriminating clinically active (DAS28 ≥ 3.2) from less active (DAS28 ≤ 3.2) RA
- Mixed-effect analysis of covariance (ANCOVA) models used to assess utility of adding MS duration to Routine Assessment of Patient Index Data (RAPID) 3, a PRO index based on physical function, pain, and general health (GH), in predicting 3-variable DAS28 (DAS28v3)
- MS duration had moderate correlation with pain, Health Assessment Questionnaire, and GH; and weak correlation with joint counts and ESR
- MS duration differed significantly among patients with different RA activity
- Area under ROC curve of 0.74 (95% CI 0.72–0.75) showed moderate ability of MS duration to differentiate clinically active from less active RA
- ANCOVA showed significant interactive effects between RAPID3 and the MS duration categories in predicting DAS28v3
- Effect of MS found to be clinically important in patients with low RAPID3 scores (< 6) in whom presence of MS may indicate clinically active disease (DAS28v3 > 3.2)
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production
Arthritis Research & Therapy, 11/25/09
Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis
Annals of Rheumatic Diseases, 11/24/09
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis
Annals of Rheumatic Diseases, 11/23/09
Sponsor
Article Search
Sponsor